Clinical Trial Update: Efficacy and Safety of ETX-018810 for the Treatment of Diabetic Peripheral Neuropathic Pain [Phase 2]

View source ↗

Summary

Phase 2 trial results for ETX-018810 in diabetic peripheral neuropathic pain and diabetic peripheral neuropathy have been posted following completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathic Pain
• Diabetic Peripheral Neuropathy

Drugs mentioned

• ETX-018810

Snippet

Sponsor: Eliem Therapeutics (UK) Ltd. | Conditions: Diabetic Peripheral Neuropathic Pain, Diabetic Peripheral Neuropathy | Phase 2 | Status: COMPLETED | Results posted: 2023-05-16